Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Windlas Biotech has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, November 8, 2023, to consider and approve the un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2023. In accordance with the Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015, the Trading Window of the Company is already closed from October 1, 2023, vide its letter dated September 30, 2023, and it shall reopen on November 11, 2023.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: